Article
Angiotensin receptor-binding protein ATRAP/Agtrap inhibits metabolic dysfunction with visceral obesity.
Journal of the American Heart Association - 31 Jul 2013
Maeda Akinobu, Tamura Kouichi, Wakui Hiromichi, Dejima Toru, Ohsawa Masato, Azushima Kengo, Kanaoka Tomohiko, Uneda Kazushi, Matsuda Miyuki, Yamashita Akio, Miyazaki Nobuko, Yatsu Keisuke, Hirawa Nobuhito, Toya Yoshiyuki, Umemura Satoshi
Abstract excerpt
BACKGROUND: Metabolic disorders with visceral obesity have become a major medical problem associated with the development of hypertension, type 2 diabetes, and dyslipidemia and, ultimately, life-threatening cardiovascular and renal diseases. Adipose tissue dysfunction has been proposed as the cause of visceral obesity-related metabolic disorders, moving the tissue toward a proinflammatory phenotype. METHODS AND...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
